The Continuum MR Infusion System is now cleared for use in MR environments up to and including 3.0T, enabling clinicians to infuse medications, sedatives and other drugs while benefiting from Continuum's dose enhancements.
June 17, 2013 — Valtech Cardio Ltd. announced that two patients diagnosed with severe mitral regurgitation (MR) have been treated successfully with its Transfemoral Cardioband Annuloplasty System...
June 13, 2013 — Abbott announced publication of positive outcomes from two European post-approval studies of the catheter-based MitraClip therapy for the treatment of...
